Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank

被引:6
|
作者
Heo, Ga Young [1 ]
Koh, Hee Byung [3 ]
Jung, Chan-Young [2 ]
Park, Jung Tak [1 ]
Han, Seung Hyeok [1 ]
Yoo, Tae-Hyun [1 ]
Kang, Shin-Wook [1 ]
Kim, Hyung Woo [1 ,4 ,5 ]
机构
[1] Yonsei Univ, Inst Kidney Dis Res, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Nephrol, Seoul, South Korea
[3] Catholic Kwandong Univ, Int St Marys Hosp, Div Nephrol, Kangnung, South Korea
[4] Yonsei Univ, Inst Innovat Digital Healthcare, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
GLOMERULAR-FILTRATION-RATE; SHRUNKEN PORE SYNDROME; CHRONIC KIDNEY-DISEASE; HEART; RISK; SERUM; ATHEROSCLEROSIS; ALBUMINURIA; POPULATION; MORTALITY;
D O I
10.1053/j.ajkd.2023.11.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: The difference between cystatin C-based and creatinine-based estimated glomerular filtration rate (eGFR(diff)) has been suggested to reflect factors distinct from kidney function that are associated with cardiovascular risk. However, the association between eGFR(diff) and atrial fibrillation (AF) risk has not been extensively evaluated. Study Design: Prospective cohort study. Setting & Participants: Using data from the UK Biobank, this study included 363,494 participants with measured serum creatinine and cystatin C levels and without a prior diagnosis of AF or a history of related procedures. Exposure: Estimated GFR(diff), calculated as cystatin C-based eGFR minus creatinine-based eGFR. Estimated GFR(diff) was also categorized as negative (<-15 mL/min/1.73 m(2)), midrange (-15 to 15 mL/min/1.73 m(2)), or positive (>= 15 mL/min/1.73 m(2)). Outcome: Incident AF. Analytical Approach: Subdistribution hazard models were fit, treating death that occurred before development of AF as a competing event. Results: During the median follow-up period of 11.7 years, incident AF occurred in 18,994 (5.2%) participants. In the multivariable-adjusted model, participants with a negative eGFR(diff) had a higher risk of incident AF (subdistribution HR [SHR], 1.25 [95% CI, 1.20-1.30]), whereas participants with a positive eGFR(diff) had a lower risk of AF (SHR, 0.81 [95% CI, 0.77-0.87]) compared with those with a midrange eGFR(diff). When eGFR(diff) was treated as a continuous variable in the adjusted model, every 10 mL/min/1.73 m(2) higher eGFR(diff) was associated with a 0.90-fold decrease in the risk of incident AF. Limitations: A single measurement of baseline serum creatinine and cystatin C levels. Conclusions: The difference between cystatin C- and creatinine-based eGFRs was associated with the risk of AF development. A higher eGFR(diff) was associated with a lower risk of AF. These findings may have implications for the management of patients at risk of incident AF.
引用
收藏
页码:729 / 738.e1
页数:11
相关论文
共 50 条
  • [1] Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A New Instrument on the Horizon to Improve Risk Assessment in This High-Risk Population?
    Silva, Veronica T. Costa e
    Adingwupu, Ogechi M.
    Inker, Lesley A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (06) : 704 - 706
  • [2] Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
    Chen, Debbie C.
    Lu, Kaiwei
    Scherzer, Rebecca
    Lees, Jennifer S.
    Rutherford, Elaine
    Mark, Patrick B.
    Potok, O. Alison
    Rifkin, Dena E.
    Ix, Joachim H.
    Shlipak, Michael G.
    Estrella, Michelle M.
    KIDNEY MEDICINE, 2024, 6 (04)
  • [3] The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS)
    Potok, O. Alison
    Katz, Ronit
    Bansal, Nisha
    Siscovick, David S.
    Odden, Michelle C.
    Ix, Joachim H.
    Shlipak, Michael G.
    Rifkin, Dena E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (06) : 896 - 898
  • [4] Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort Study
    Gottlieb, Eric Raphael
    Estiverne, Christopher
    Tolan, Nicole, V
    Melanson, Stacy E. F.
    Mendu, Mallika L.
    KIDNEY MEDICINE, 2023, 5 (03)
  • [5] Cystatin-Based Estimated GFR Versus Creatinine-Based and Creatinine- and Cystatin-Based Estimated GFR for ESRD and Mortality Risk in Diabetes
    Skupien, Jan
    Warram, James H.
    Groop, Per-Henrik
    Krolewski, Andrzej S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (01) : 184 - 186
  • [6] The association between the cystatin C- and creatinine-based estimated GFR ratio and post-ablation outcomes in patients with atrial fibrillation
    Huang, Wenchao
    Shang, Luxiang
    Luo, Yan
    Xiong, Shiqiang
    Suo, Shuwei
    Zhang, Zhen
    Liu, Hanxiong
    Sun, Huaxin
    RENAL FAILURE, 2025, 47 (01)
  • [7] Correlation Between Symmetric Dimethylarginine, Creatinine, Estimated GFR, and Cystatin C
    Song, Jie
    Lee, Christine C.
    Zibrat, Steven J.
    Toney, Leighton
    Yeo, Kiang-Teck J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 500 - 500
  • [8] Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure
    Chen, Debbie C.
    Shlipak, Michael G.
    Scherzer, Rebecca
    Bansal, Nisha
    Potok, O. Alison
    Rifkin, Dena E.
    Ix, Joachim H.
    Muiru, Anthony N.
    Hsu, Chi-Yuan
    Estrella, Michelle M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (06) : 762 - +
  • [9] CONCORDANCE OF ESTIMATED GFR BASED ON CREATININE AND CYSTATIN C IN A BROAD NEPHROLOGICAL POPULATION
    Musters, Marin
    Den Bakkker, Emil
    Hubeek, Isabelle
    Van Wijk, Joanna
    Gemke, Reinoud
    Bokenkamp, Arend
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1873 - 1873
  • [10] Estimated GFR with Creatinine and Cystatin C in clinical practice: a single centre study
    Ng, Natasha Su Lynn
    Kargbo, Caroline
    Holt, Richard
    Oni, Louise
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S105 - S105